EPISODE · Feb 8, 2018 · 9 MIN
Can DAA therapy for HCV reactivate HBV in coinfected patients?
from Listen to The Lancet Gastroenterology & Hepatology · host The Lancet
In this Lancet Gastroenterology & Hepatology podcast, Johannes Vermehren discusses the risks of Hepatitis B reactivation in coinfected patients receiving treatment for Hepatitis C.
Embed this episode
NOW PLAYING
Can DAA therapy for HCV reactivate HBV in coinfected patients?
0:00
9:10
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet Gastroenterology & Hepatology?
This episode is 9 minutes long.
When was this Listen to The Lancet Gastroenterology & Hepatology episode published?
This episode was published on February 8, 2018.
Can I download this Listen to The Lancet Gastroenterology & Hepatology episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!